Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Condition:   Rheumatoid Arthritis Interventions:   Drug: Rebamipide;   Drug: Nanoparticulated Rebamipide;   Drug: Clobetasol Propionate Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2020 Category: Research Source Type: clinical trials